about
Effect of fasting on temporal variation in the nephrotoxicity of amphotericin B in ratsIdentification of Adjuvantic Activity of Amphotericin B in a Novel, Multiplexed, Poly-TLR/NLR High-Throughput Screen.Amphotericin B in lipid emulsion: stability, compatibility, and in vitro antifungal activity.Safety and toxicity of amphotericin B in glucose 5% or intralipid 20% in neutropenic patients with pneumonia or fever of unknown origin: randomised study.Comparison of the toxicity of amphotericin B in 5% dextrose with that of amphotericin B in fat emulsion in a randomized trial with cancer patientsMethod for measuring postantifungal effect in Aspergillus species.Toxicity and antileishmanial activity of a new stable lipid suspension of amphotericin B.Improving outcome of treatment of kala-azar by supplementation of amphotericin B with physiologic saline and potassium chloride.Amphotericin B and its new formulations: pharmacologic characteristics, clinical efficacy, and tolerability.Therapy of visceral leishmaniasis due to Leishmania infantum: experimental assessment of efficacy of AmBisome.Serum pharmacology of amphotericin B applied in lipid emulsions.Activity of liposomal amphotericin B against experimental cutaneous leishmaniasis.Pharmacokinetics of liposomal amphotericin B (Ambisome) in critically ill patientsCurrent perspectives on ophthalmic mycosesCryptococcal Meningitis: Diagnosis and Management Update.Characterization of a Polyethylene Glycol-Amphotericin B Conjugate Loaded with Free AMB for Improved Antifungal Efficacy.Amantelides A and B, Polyhydroxylated Macrolides with Differential Broad-Spectrum Cytotoxicity from a Guamanian Marine Cyanobacterium.Synthesis of a highly water-soluble derivative of amphotericin B with attenuated proinflammatory activity.Clinical utility of voriconazole eye drops in ophthalmic fungal keratitis.Topical delivery of antifungal agents.The impact of antifungals on toll-like receptorsTime-Kill Kinetics and In Vitro Antifungal Susceptibility of Non-fumigatus Aspergillus Species Isolated from Patients with Ocular Mycoses.Liposomal amphotericin B (AmBisome®) at beginning of its third decade of clinical use.Liposomal Amphotericin B for the Treatment of Cryptococcal Meningitis in HIV/AIDS Patients in India-A Pilot Pharmacokinetic Study.Administration of lipid-emulsion versus conventional amphotericin B in patients with neutropenia.Epidemiology, diagnosis and treatment of systemic Candida infection in surgical patients under intensive care.In search of the amazing technicolour dream coat for amphotericin B.Amphotericin B-associated hypertension.PHARMACOKINETIC STUDIES OF IN-SITU LIPOSOMAL PREPARATION CONTAINING AMPHOTERICIN B COMPLEXED WITH DIFFERENT CHEMICALLY MODIFIED beta-CYCLODEXTRINS.Cholesterol-lowering drug, in combination with chromium chloride, induces early apoptotic signals in intracellular L. donovani amastigotes, leading to death.Antifungal therapy: drug-drug interactions at your fingertips.Efficacy and safety of amphotericin B lipid complex injection (ABLC) in solid-organ transplant recipients with invasive fungal infections.Unfair book reviews?
P2860
Q28343168-A7C30373-B060-40E3-B9C6-2699E00274A7Q30388683-585EA50A-8C58-43C0-AE85-89230A6EEFF9Q33692176-6CDA884E-CF1D-4203-9792-5E9C36883F8BQ33824631-82E2C50F-DE11-47AD-8D1A-742BEFBEA999Q33976955-38EDEB12-914C-4942-BFE2-C79ABCD5DBAEQ34108018-5A6DA3BD-0D31-4C79-B4AB-0A0DA222B039Q34230457-6FBAA12D-2D15-486B-90BC-C8C3B3AAAE57Q34240036-9BD2A5BF-5CB3-46C6-A43D-86891CAB4872Q34294886-34E3B927-2C0A-48B6-BAE0-353E30453799Q35124422-47E246D5-85D4-48A2-ADB1-DBDB99EF44D9Q35134565-ECCD7B6C-FCF2-40C2-8F58-D99636407B70Q35134721-18F59F4D-B67F-4A17-9FCF-4A9157C48CD1Q35136556-71087101-111B-4EE2-94CF-116531317550Q35558829-3F059504-2081-498D-9D32-9936EF8BF9A3Q35951094-BCB643F3-9021-47FC-964B-354B9EA96BB3Q35967724-6220CD86-98CF-4C2B-A380-C7A8E1F2745DQ36497566-F25A55E9-06D9-44D5-9278-1A51EC5B08E0Q37005474-CE323A65-4455-4915-B2A7-C86B29B22457Q37750488-41FA1222-D7FD-4F6F-AE06-EEBC09B4BD17Q37801662-FD130DD4-8B2D-4014-89B4-A65646D78057Q38199674-530E06BF-4504-4107-AEE2-6D514AE0314EQ38914243-8DBCF7D1-105C-410A-8453-7DB9C4ADA2F5Q39196802-168DC016-6B8E-4D3E-A2EB-E0316464BE7CQ39816525-89662DAA-FC0A-493C-B345-6D73D486A6FFQ40677144-C3EF41F1-CE52-4CB2-BE98-D69E7ECCD952Q41753239-09598C90-B882-4CA5-BEB0-118698087FF8Q42544559-D99B77BE-519F-4237-B4EA-B29D5B4933AEQ42553772-34EBCC48-8FAD-4A00-82EA-47200079D45EQ45967355-22989FD2-0933-491C-8010-B1F18D0FB941Q49866040-B12DB416-AA48-4DF2-BA3B-FC5BA6BAA086Q53289209-1E3B5A34-AA39-4CD0-B8FE-B695B9435564Q53906467-A358A9C4-0115-4B30-B3EA-34F7A06CEC02Q55073143-8300B430-A377-4AED-A96E-8D0F52F1AD07
P2860
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
Administering amphotericin B--a practical approach.
@en
Administering amphotericin B--a practical approach.
@nl
type
label
Administering amphotericin B--a practical approach.
@en
Administering amphotericin B--a practical approach.
@nl
prefLabel
Administering amphotericin B--a practical approach.
@en
Administering amphotericin B--a practical approach.
@nl
P2093
P356
P1476
Administering amphotericin B--a practical approach.
@en
P2093
P304
P356
10.1093/JAC/33.2.203
P407
P577
1994-02-01T00:00:00Z